The current revolution in genomics makes it possible not only to determine our entire DNA sequence but also to begin to understand how our specific genome sequence can inform our health. In addition, our Center has recently demonstrated that it is possible to measure tens of thousands of components in blood to obtain a clear picture of our molecular picture during healthy and disease states. Join us and discuss the most recent findings.
We welcome our two keynote speakers:
- Tuuli Lappalainen, PhD., Senior Associate Member, New York Genome Center and Genomics Professor at KTH Royal Institute of Technology
- Manolis Dermitzakis, PhD., VP, Computational Biology, Genomic Sciences, GSK
THANK YOU TO OUR SPONSORS!
GOLD LEVEL: GSK, Illumina, Latham & Watkins, Seer, Thermo Fischer, 10xGenomics
SILVER LEVEL: Fulgent Genetics, Mayfield Fund, Ultima
BRONZE LEVEL: Insilico Medicine, Olink
